The Evolution of Genetics: Alzheimer's and Parkinson's Diseases

Neuron

Volumn 90, Issue 6, 2016, Pages 1154-1163

  Singleton, Andrew ^a   Hardy, John ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Alzheimer's disease; Exome sequencing; Genetics; Genome wide association; Parkinson's disease

Indexed keywords

ALZHEIMER DISEASE; CLINICAL RESEARCH; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC RISK; GENETICS; HUMAN; HUMAN GENOME; HYPOTHESIS; MOLECULAR GENETICS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; THERAPY; UNCERTAINTY; GENETIC PREDISPOSITION; MEDICAL GENETICS; METHODOLOGY; MUTATION; TRENDS;

ALZHEIMER DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, MEDICAL; HUMANS; MUTATION; PARKINSON DISEASE; RESEARCH DESIGN;

EID: 84973915581     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2016.05.040     Document Type: Review

References (63)

1. Beilina A., Rudenko I.N., Kaganovich A., Civiero L., Chau H., Kalia S.K., Kalia L.V., Lobbestael E., Chia R., Ndukwe K., et al. Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease. Proc. Natl. Acad. Sci. USA 2014, 111:2626-2631. International Parkinson's Disease Genomics Consortium, North American Brain Expression ConsortiumNorth American Brain Expression Consortium.
2. Bonifati V., Rizzu P., van Baren M.J., Schaap O., Breedveld G.J., Krieger E., Dekker M.C.J., Squitieri F., Ibanez P., Joosse M., et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003, 299:256-259.
3. Chartier-Harlin M.-C., Dachsel J.C., Vilariño-Güell C., Lincoln S.J., Leprêtre F., Hulihan M.M., Kachergus J., Milnerwood A.J., Tapia L., Song M.-S., et al. Translation initiator EIF4G1 mutations in familial Parkinson disease. Am. J. Hum. Genet. 2011, 89:398-406.
4. Claussnitzer M., Dankel S.N., Kim K.-H., Quon G., Meuleman W., Haugen C., Glunk V., Sousa I.S., Beaudry J.L., Puviindran V., et al. FTO obesity variant circuitry and adipocyte browning in humans. N. Engl. J. Med. 2015, 373:895-907.
5. Cruts M., Theuns J., Van Broeckhoven C. Locus-specific mutation databases for neurodegenerative brain diseases. Hum. Mutat. 2012, 33:1340-1344.
6. Do C.B., Tung J.Y., Dorfman E., Kiefer A.K., Drabant E.M., Francke U., Mountain J.L., Goldman S.M., Tanner C.M., Langston J.W., et al. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet. 2011, 7:e1002141.
7. Edwards T.L., Scott W.K., Almonte C., Burt A., Powell E.H., Beecham G.W., Wang L., Züchner S., Konidari I., Wang G., et al. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann. Hum. Genet. 2010, 74:97-109.
8. Elbaz A., Ross O.A., Ioannidis J.P.A., Soto-Ortolaza A.I., Moisan F., Aasly J., Annesi G., Bozi M., Brighina L., Chartier-Harlin M.-C., et al. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Ann. Neurol. 2011, 69:778-792. Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.
9. Funayama M., Ohe K., Amo T., Furuya N., Yamaguchi J., Saiki S., Li Y., Ogaki K., Ando M., Yoshino H., et al. CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study. Lancet Neurol. 2015, 14:274-282.
10. Gamazon E.R., Wheeler H.E., Shah K.P., Mozaffari S.V., Aquino-Michaels K., Carroll R.J., Eyler A.E., Denny J.C., Nicolae D.L., Cox N.J., Im H.K. A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet. 2015, 47:1091-1098. GTEx Consortium.
11. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991, 349:704-706.
12. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 2013, 45:580-585. GTEx Consortium.
13. Guerreiro R.J., Lohmann E., Brás J.M., Gibbs J.R., Rohrer J.D., Gurunlian N., Dursun B., Bilgic B., Hanagasi H., Gurvit H., et al. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. JAMA Neurol. 2012, 70:78-84.
14. Guerreiro R., Wojtas A., Bras J., Carrasquillo M., Rogaeva E., Majounie E., Cruchaga C., Sassi C., Kauwe J.S.K., Younkin S., et al. TREM2 variants in Alzheimer's disease. N. Engl. J. Med. 2013, 368:117-127.
15. Guerreiro R., Escott-Price V., Darwent L., Parkkinen L., Ansorge O., Hernandez D.G., Nalls M.A., Clark L., Honig L., Marder K., et al. Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases. Neurobiol. Aging 2015, 38:214.e7-214.e10. International Parkinson's Disease Genomics Consortium (IPDGC).
16. Hamza T.H., Zabetian C.P., Tenesa A., Laederach A., Montimurro J., Yearout D., Kay D.M., Doheny K.F., Paschall J., Pugh E., et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat. Genet. 2010, 42:781-785.
17. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A., et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 2009, 41:1088-1093.
18. Hernandez D.G., Nalls M.A., Ylikotila P., Keller M., Hardy J.A., Majamaa K., Singleton A.B. Genome wide assessment of young onset Parkinson's disease from Finland. PLoS ONE 2012, 7:e41859.
19. Hollingworth P., Harold D., Sims R., Gerrish A., Lambert J.-C., Carrasquillo M.M., Abraham R., Hamshere M.L., Pahwa J.S., Moskvina V., et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet. 2011, 43:429-435. Alzheimer's Disease Neuroimaging Initiative, CHARGE consortiumCHARGE consortium, EADI1 consortiumEADI1 consortium.
20. Holmans P., Moskvina V., Jones L., Sharma M., Vedernikov A., Buchel F., Saad M., Bras J.M., Bettella F., Nicolaou N., et al. A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease. Hum. Mol. Genet. 2013, 22:1039-1049. International Parkinson's Disease Genomics Consortium.
21. Convergent genetic and expression data implicate immunity in Alzheimer's disease. Alzheimers Dement. 2015, 11:658-671. International Genomics of Alzheimer's Disease Consortium (IGAP).
22. A two-stage meta-analysis identifies several new loci for Parkinson's disease. PLoS Genet. 2011, 7:e1002142. International Parkinson's Disease Genomics Consortium (IPDGC), Wellcome Trust Case Control Consortium 2 (WTCCC2)Wellcome Trust Case Control Consortium 2 (WTCCC2).
23. Jones L., Holmans P.A., Hamshere M.L., Harold D., Moskvina V., Ivanov D., Pocklington A., Abraham R., Hollingworth P., Sims R., et al. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS ONE 2010, 5:e13950.
24. Jonsson T., Stefansson H., Steinberg S., Jonsdottir I., Jonsson P.V., Snaedal J., Bjornsson S., Huttenlocher J., Levey A.I., Lah J.J., et al. Variant of TREM2 associated with the risk of Alzheimer's disease. N. Engl. J. Med. 2013, 368:107-116.
25. Keller M.F., Saad M., Bras J., Bettella F., Nicolaou N., Simón-Sánchez J., Mittag F., Büchel F., Sharma M., Gibbs J.R., et al. Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease. Hum. Mol. Genet. 2012, 21:4996-5009. International Parkinson's Disease Genomics Consortium (IPDGC), Wellcome Trust Case Control Consortium 2 (WTCCC2)Wellcome Trust Case Control Consortium 2 (WTCCC2).
26. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392:605-608.
27. Lambert J.-C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B., et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 2009, 41:1094-1099. European Alzheimer's Disease Initiative Investigators.
28. Lambert J.C., Ibrahim-Verbaas C.A., Harold D., Naj A.C., Sims R., Bellenguez C., DeStafano A.L., Bis J.C., Beecham G.W., Grenier-Boley B., et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat. Genet. 2013, 45:1452-1458. European Alzheimer's Disease Initiative (EADI), Genetic and Environmental Risk in Alzheimer's DiseaseGenetic and Environmental Risk in Alzheimer's Disease, Alzheimer's Disease Genetic ConsortiumAlzheimer's Disease Genetic Consortium, Cohorts for Heart and Aging Research in Genomic EpidemiologyCohorts for Heart and Aging Research in Genomic Epidemiology.
29. Leroy E., Boyer R., Auburger G., Leube B., Ulm G., Mezey E., Harta G., Brownstein M.J., Jonnalagada S., Chernova T., et al. The ubiquitin pathway in Parkinson's disease. Nature 1998, 395:451-452.
30. Lill C.M., Roehr J.T., McQueen M.B., Kavvoura F.K., Bagade S., Schjeide B.-M.M., Schjeide L.M., Meissner E., Zauft U., Allen N.C., et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet. 2012, 8:e1002548. 23andMe Genetic Epidemiology of Parkinson's Disease Consortium, International Parkinson's Disease Genomics ConsortiumInternational Parkinson's Disease Genomics Consortium, Parkinson's Disease GWAS ConsortiumParkinson's Disease GWAS Consortium, Wellcome Trust Case Control Consortium 2)Wellcome Trust Case Control Consortium 2).
31. Liu X., Cheng R., Verbitsky M., Kisselev S., Browne A., Mejia-Sanatana H., Louis E.D., Cote L.J., Andrews H., Waters C., et al. Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population. BMC Med. Genet. 2011, 12:104.
32. MacArthur D.G., Manolio T.A., Dimmock D.P., Rehm H.L., Shendure J., Abecasis G.R., Adams D.R., Altman R.B., Antonarakis S.E., Ashley E.A., et al. Guidelines for investigating causality of sequence variants in human disease. Nature 2014, 508:469-476.
33. Moskvina V., Harold D., Russo G., Vedernikov A., Sharma M., Saad M., Holmans P., Bras J.M., Bettella F., Keller M.F., et al. Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk. JAMA Neurol. 2013, 70:1268-1276. IPDGC and GERAD Investigators.
34. Mueller S.G., Weiner M.W., Thal L.J., Petersen R.C., Jack C.R., Jagust W., Trojanowski J.Q., Toga A.W., Beckett L. Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement. 2005, 1:55-66.
35. Naj A.C., Jun G., Beecham G.W., Wang L.-S., Vardarajan B.N., Buros J., Gallins P.J., Buxbaum J.D., Jarvik G.P., Crane P.K., et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 2011, 43:436-441.
36. Nalls M.A., Plagnol V., Hernandez D.G., Sharma M., Sheerin U.M., Saad M., Simón-Sánchez J., Schulte C., Lesage S., Sveinbjörnsdóttir S., et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011, 377:641-649. International Parkinson Disease Genomics Consortium.
37. Nalls M., Pankratz N., Lill C.M., Do C.B., Hernandez D.G., Saad M., DeStefano A.L., Kara E., Bras J., Sharma M., et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat. Genet. 2014, 46:989-993. International Parkinson's Disease Genomics Consortium (IPDGC), Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI)Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe23andMe, GenePDGenePD, NeuroGenetics Research Consortium (NGRC)NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG)Hussman Institute of Human Genomics (HIHG), Ashkenazi Jewish Dataset Investigator; Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE)Ashkenazi Jewish Dataset Investigator; Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE), North American Brain Expression Consortium (NABEC)North American Brain Expression Consortium (NABEC), United Kingdom Brain Expression Consortium (UKBEC)United Kingdom Brain Expression Consortium (UKBEC), Greek Parkinson's Disease ConsortiumGreek Parkinson's Disease Consortium, Alzheimer Genetic Analysis GroupAlzheimer Genetic Analysis Group.
38. Nalls M.A., Saad M., Noyce A.J., Keller M.F., Schrag A., Bestwick J.P., Traynor B.J., Gibbs J.R., Hernandez D.G., Cookson M.R., et al. Genetic comorbidities in Parkinson's disease. Hum. Mol. Genet. 2014, 23:831-841. International Parkinson's Disease Genomics Consortium (IPDGC), Wellcome Trust Case Control Consortium 2 (WTCCC2)Wellcome Trust Case Control Consortium 2 (WTCCC2), North American Brain Expression Consortium (NABEC)North American Brain Expression Consortium (NABEC), United Kingdom Brain Expression Consortium (UKBEC)United Kingdom Brain Expression Consortium (UKBEC).
39. Novarino G., Fenstermaker A.G., Zaki M.S., Hofree M., Silhavy J.L., Heiberg A.D., Abdellateef M., Rosti B., Scott E., Mansour L., et al. Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. Science 2014, 343:506-511.
40. Paisán-Ruíz C., Jain S., Evans E.W., Gilks W.P., Simón J., van der Brug M., López de Munain A., Aparicio S., Gil A.M., Khan N., et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004, 44:595-600.
41. Paloneva J., Manninen T., Christman G., Hovanes K., Mandelin J., Adolfsson R., Bianchin M., Bird T., Miranda R., Salmaggi A., et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am. J. Hum. Genet. 2002, 71:656-662.
42. Pankratz N., Wilk J.B., Latourelle J.C., DeStefano A.L., Halter C., Pugh E.W., Doheny K.F., Gusella J.F., Nichols W.C., Foroud T., Myers R.H. Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum. Genet. 2009, 124:593-605. PSG-PROGENI and GenePD Investigators, Coordinators and Molecular Genetic Laboratories.
43. Pankratz N., Beecham G.W., DeStefano A.L., Dawson T.M., Doheny K.F., Factor S.A., Hamza T.H., Hung A.Y., Hyman B.T., Ivinson A.J., et al. Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Ann. Neurol. 2012, 71:370-384. PD GWAS Consortium.
44. The Parkinson Progression Marker Initiative (PPMI). Prog. Neurobiol. 2011, 95:629-635. Parkinson Progression Marker Initiative.
45. Pihlstrøm L., Axelsson G., Bjørnarå K.A., Dizdar N., Fardell C., Forsgren L., Holmberg B., Larsen J.P., Linder J., Nissbrandt H., et al. Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease. Neurobiol. Aging 2013, 34:1708.e7-1708.e13.
46. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
47. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995, 376:775-778.
48. Saad M., Lesage S., Saint-Pierre A., Corvol J.-C., Zelenika D., Lambert J.-C., Vidailhet M., Mellick G.D., Lohmann E., Durif F., et al. Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. Hum. Mol. Genet. 2011, 20:615-627. French Parkinson's Disease Genetics Study Group.
49. Satake W., Nakabayashi Y., Mizuta I., Hirota Y., Ito C., Kubo M., Kawaguchi T., Tsunoda T., Watanabe M., Takeda A., et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet. 2009, 41:1303-1307.
50. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 1996, 2:864-870.
51. Seshadri S., Fitzpatrick A.L., Ikram M.A., DeStefano A.L., Gudnason V., Boada M., Bis J.C., Smith A.V., Carassquillo M.M., Lambert J.C., et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 2010, 303:1832-1840. CHARGE Consortium, GERAD1 ConsortiumGERAD1 Consortium, EADI1 ConsortiumEADI1 Consortium.
52. Sharma M., Ioannidis J.P.A., Aasly J.O., Annesi G., Brice A., Van Broeckhoven C., Bertram L., Bozi M., Crosiers D., Clarke C., et al. Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology 2012, 79:659-667. GEO-PD Consortium.
53. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995, 375:754-760.
54. Simón-Sánchez J., Schulte C., Bras J.M., Sharma M., Gibbs J.R., Berg D., Paisan-Ruiz C., Lichtner P., Scholz S.W., Hernandez D.G., et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 2009, 41:1308-1312.
55. Simón-Sánchez J., van Hilten J.J., van de Warrenburg B., Post B., Berendse H.W., Arepalli S., Hernandez D.G., de Bie R.M.A., Velseboer D., Scheffer H., et al. Genome-wide association study confirms extant PD risk loci among the Dutch. Eur. J. Hum. Genet. 2011, 19:655-661.
56. Singleton A., Gwinn-Hardy K. Parkinson's disease and dementia with Lewy bodies: a difference in dose?. Lancet 2004, 364:1105-1107.
57. Singleton A., Hardy J. A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci. Hum. Mol. Genet. 2011, 20(R2):R158-R162.
58. Smemo S., Tena J.J., Kim K.-H., Gamazon E.R., Sakabe N.J., Gómez-Marín C., Aneas I., Credidio F.L., Sobreira D.R., Wasserman N.F., et al. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 2014, 507:371-375.
59. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M.K., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G., et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004, 304:1158-1160.
60. Vilariño-Güell C., Wider C., Ross O.A., Dachsel J.C., Kachergus J.M., Lincoln S.J., Soto-Ortolaza A.I., Cobb S.A., Wilhoite G.J., Bacon J.A., et al. VPS35 mutations in Parkinson disease. Am. J. Hum. Genet. 2011, 89:162-167.
61. Vilariño-Güell C., Rajput A., Milnerwood A.J., Shah B., Szu-Tu C., Trinh J., Yu I., Encarnacion M., Munsie L.N., Tapia L., et al. DNAJC13 mutations in Parkinson disease. Hum. Mol. Genet. 2014, 23:1794-1801.
62. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R.J., Calne D.B., et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004, 44:601-607.
63. Zimprich A., Benet-Pagès A., Struhal W., Graf E., Eck S.H., Offman M.N., Haubenberger D., Spielberger S., Schulte E.C., Lichtner P., et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am. J. Hum. Genet. 2011, 89:168-175.